Integrated Biosciences Raises $17 Million to Accelerate Development of Drugs Targeting Age-Related Diseases
October 03, 2024 08:00 AM Eastern Daylight Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–Integrated Biosciences, a biotechnology company pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases, today announced that…